Dr Kathy Liddell has been appointed to the Expert Board for Copenhagen Economics’ successful proposal to the European Commission (DG GROW) to prepare its “Study on the economic impact of SPCs, Pharmaceutical incentives and rewards in Europe”.
The overall objective of the project is to shed light on the effects of IP-related incentives (in particular Supplementary Protection Certificates) for innovation, availability and accessibility of pharmaceutical products in the European Union.
The team at Copenhagen Economics has extensive experience performing economic analyses and providing advice to the European Commission as well as to numerous clients in the pharmaceutical industry.
The Expert Board will act as a close partner on the project providing professional assistance and expert insights. It consists of five well known international academics – Dr Kathy Liddell (Cambridge), Prof Timo Minssen (Copenhagen), Prof Brian Wright (Berkeley), Prof Jacques Pelkmans (CEP), Prof Jakob Kjellberg (KORA) -- each with their own respective area of expertise, covering legislationwith a special focus on patents and intellectual property, econometricsand health economics.